Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Enhanced Photodynamic Anticancer Activities of Multifunctional Magnetic Nanoparticles (Fe3O4) Conjugated with Chlorin e6 and Folic Acid in Prostate and Breast Cancer Cells

Kyong‐Hoon ChoiInstitute of Biomaterials, Kwangwoon University, Nowon-gu, Seoul 01897, KoreaKi Chang NamDepartment of Medical Engineering, Dongguk University College of Medicine, Gyeonggi-do 10326, KoreaGuangsup ChoDepartment of Electrical & Biological Physics, Kwangwoon University, Nowon-gu, Seoul 01897, KoreaJin-Seung JungDepartment of Chemistry, Gangneung-Wonju National University, Gangneung 25457, KoreaBong Joo ParkDepartment of Electrical & Biological Physics, Kwangwoon University, Nowon-gu, Seoul 01897, Korea
2018en
ABI

Аннотация

Photodynamic therapy (PDT) is a promising alternative to conventional cancer treatment methods. Nonetheless, improvement of in vivo light penetration and cancer cell-targeting efficiency remain major challenges in clinical photodynamic therapy. This study aimed to develop multifunctional magnetic nanoparticles conjugated with a photosensitizer (PS) and cancer-targeting molecules via a simple surface modification process for PDT. To selectively target cancer cells and PDT functionality, core magnetic (Fe₃O₄) nanoparticles were covalently bound with chlorin e6 (Ce6) as a PS and folic acid (FA). When irradiated with a 660-nm long-wavelength light source, the Fe₃O₄-Ce6-FA nanoparticles with good biocompatibility exerted marked anticancer effects via apoptosis, as confirmed by analyzing the translocation of the plasma membrane, nuclear fragmentation, activities of caspase-3/7 in prostate (PC-3) and breast (MCF-7) cancer cells. Ce6, used herein as a PS, is thus more useful for PDT because of its ability to produce a high singlet oxygen quantum yield, which is owed to deep penetration by virtue of its long-wavelength absorption band; however, further in vivo studies are required to verify its biological effects for clinical applications.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0